A Randomized Clinical Trial of Oxytocin or Galantamine for the Treatment of Negative Symptoms and Cognitive Impairments in People With Schizophrenia.

about

The effects of oxytocin and galantamine on objectively-defined vocal and facial expression: Data from the CIDAR study.Efficacy of different types of cognitive enhancers for patients with schizophrenia: a meta-analysis

P2860

Q31157357-6CA36937-0BE7-4D9D-95C3-7724840CBB2E Q58561523-F20689AE-9E42-411E-BE74-B38D13CBAEEF

P2860

A Randomized Clinical Trial of Oxytocin or Galantamine for the Treatment of Negative Symptoms and Cognitive Impairments in People With Schizophrenia.

Item

http://www.wikidata.org/entity/Q47701023

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

A Randomized Clinical Trial of ...... in People With Schizophrenia.

@en

A Randomized Clinical Trial of ...... in People With Schizophrenia.

@nl

type

Item

label

A Randomized Clinical Trial of ...... in People With Schizophrenia.

@en

A Randomized Clinical Trial of ...... in People With Schizophrenia.

@nl

prefLabel

A Randomized Clinical Trial of ...... in People With Schizophrenia.

@en

A Randomized Clinical Trial of ...... in People With Schizophrenia.

@nl

P1476

A Randomized Clinical Trial of ...... in People With Schizophrenia.

@en

P2093

Deanna L Kelly

http://www.w3.org/2001/XMLSchema#string

Elaine Weiner

http://www.w3.org/2001/XMLSchema#string

Gregory P Strauss

http://www.w3.org/2001/XMLSchema#string

James M Gold

http://www.w3.org/2001/XMLSchema#string

Maju M Koola

http://www.w3.org/2001/XMLSchema#string

Robert P McMahon

http://www.w3.org/2001/XMLSchema#string

Robert W Buchanan

http://www.w3.org/2001/XMLSchema#string

William T Carpenter

http://www.w3.org/2001/XMLSchema#string

P2860

Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia

A double-blind randomized controlled trial of oxytocin nasal spray and social cognition training for young people with early psychosis

Oxytocin increases trust in humans

A rating scale for drug-induced akathisia

Diminished plasma oxytocin in schizophrenic patients with neuroendocrine dysfunction and emotional deficits

Neuropsychology of the deficit syndrome: new data and meta-analysis of findings to date.

The impact of missing data and how it is handled on the rate of false-positive results in drug development.

Oxytocin-augmented social cognitive skills training in schizophrenia.

UCSD Performance-Based Skills Assessment: development of a new measure of everyday functioning for severely mentally ill adults.

Effects of adjunctive intranasal oxytocin on olfactory identification and clinical symptoms in schizophrenia: results from a randomized double blind placebo controlled pilot study

P304

394-400

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/JCP.0000000000000720

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28590362

http://www.w3.org/2001/XMLSchema#string

P921

oxytocin

schizophrenia

P932

5484721

http://www.w3.org/2001/XMLSchema#string

A Randomized Clinical Trial of Oxytocin or Galantamine for the Treatment of Negative Symptoms and Cognitive Impairments in People With Schizophrenia.

about

P2860

P2860

A Randomized Clinical Trial of Oxytocin or Galantamine for the Treatment of Negative Symptoms and Cognitive Impairments in People With Schizophrenia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932